In 2011, Ngo and colleagues demonstrated that MYD88 and associated kinases (IRAK1 and IRAK4) are required for the viability of ABC DLBCLs, finding a notable frequency of MYD88 mutations in non-GCB ABC cell lines [36]. Here, IRAK4 is linked to aneurysmal bone cyst.